Literature DB >> 29779113

Preparation and Properties of Nanoparticles, tRNA-Bivalent Metal Cation (Me2+) Complexes, and Prospects of Their Practical Use.

V N Danilevich1, V V Sorokin2, Ya P Moiseev3, S V Sizova3.   

Abstract

The patterns of formation of RNA nanoparticles (NPs) during thermal cycling of bacterial total tRNA in the presence of cations Ca2+, Mn2+, Ni2+, Zn2+, Co2+, and Cu2+ were studied. The optimal conditions for the production of NPs were found, and it was revealed that their size depends on the ratio of the concentrations of Me2+ and tRNA. The concentration of reagents for obtaining NPs of small size (from 5 to 100 nm) was selected. It was shown that tRNA-based nanoparticles can comprise short (20-50 nt) ribooligonucleotides, including aptamers and siRNAs. The stability of NPs during storage in buffer solutions of various composition was studied. It was found that the initial suspensions of NPs are quite stable, but they are rapidly destroyed in PBS buffer (pH 7.4). A simple and effective stabilizer (polyarginine) was found, the additives of which ensure the preservation of nanoparticles in PBS buffer for more than 5 h. Nanoparticles modified with the stabilizer are resistant to blood serum nucleases and can be used for transfection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29779113     DOI: 10.1134/S1607672918020187

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN: 1607-6729            Impact factor:   0.788


  10 in total

Review 1.  Nanoparticles for intracellular-targeted drug delivery.

Authors:  Cristiana S O Paulo; Ricardo Pires das Neves; Lino S Ferreira
Journal:  Nanotechnology       Date:  2011-11-21       Impact factor: 3.874

Review 2.  Nonviral approach for targeted nucleic acid delivery.

Authors:  M Jafari; M Soltani; S Naahidi; D N Karunaratne; P Chen
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Rapid and efficient technique for the production of condensed DNA and RNA nanoparticles using thermal cycling.

Authors:  V N Danilevich
Journal:  Dokl Biochem Biophys       Date:  2012-05-05       Impact factor: 0.788

4.  RNA aptamers and their therapeutic and diagnostic applications.

Authors:  Katherine Germer; Marissa Leonard; Xiaoting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2013-03-31

5.  Biodegradable DNA-Brush Block Copolymer Spherical Nucleic Acids Enable Transfection Agent-Free Intracellular Gene Regulation.

Authors:  Chuan Zhang; Liangliang Hao; Colin M Calabrese; Yu Zhou; Chung Hang J Choi; Hang Xing; Chad A Mirkin
Journal:  Small       Date:  2015-08-21       Impact factor: 13.281

6.  Aggregation of melted DNA by divalent metal ion-mediated cross-linking.

Authors:  J G Duguid; V A Bloomfield
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

Review 7.  The emerging field of RNA nanotechnology.

Authors:  Peixuan Guo
Journal:  Nat Nanotechnol       Date:  2010-11-21       Impact factor: 39.213

Review 8.  Stable RNA nanoparticles as potential new generation drugs for cancer therapy.

Authors:  Yi Shu; Fengmei Pi; Ashwani Sharma; Mehdi Rajabi; Farzin Haque; Dan Shu; Markos Leggas; B Mark Evers; Peixuan Guo
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

9.  Design Considerations for RNA Spherical Nucleic Acids (SNAs).

Authors:  Stacey N Barnaby; Grant A Perelman; Kevin L Kohlstedt; Alyssa B Chinen; George C Schatz; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2016-08-14       Impact factor: 4.774

Review 10.  Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.

Authors:  Kevin B Spurgers; C Matthew Sharkey; Kelly L Warfield; Sina Bavari
Journal:  Antiviral Res       Date:  2008-01-14       Impact factor: 5.970

  10 in total
  1 in total

Review 1.  Isolation of Cell-Free miRNA from Biological Fluids: Influencing Factors and Methods.

Authors:  Olga Bryzgunova; Maria Konoshenko; Ivan Zaporozhchenko; Alexey Yakovlev; Pavel Laktionov
Journal:  Diagnostics (Basel)       Date:  2021-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.